Test Price
2,000 AED✅ Home Collection Available
IGF Binding Protein‑2 (IGFBP‑2) Test in Dubai, UAE | 2000 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Accredited Processing.
- ✓Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
- ✓Clinical Guidance: Telephonic post‑test interpretation support from a Specialist Diagnostic Radiologist.
- ✓Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Core Metrics Snapshot:
This quantitative serum assay measures insulin‑like growth factor binding protein‑2 (IGFBP‑2) using Radioimmunoassay (RIA) under ISO 9001:2015 standards. The test supports growth disorder evaluation, cancer risk stratification, and metabolic profiling, with results delivered within 2–3 weeks of specimen receipt.
Test Overview & Methodology
This laboratory analysis quantifies circulating IGFBP‑2 in serum, a major modulator of insulin‑like growth factor (IGF) bioavailability. Elevated levels are clinically associated with colorectal and breast cancer risk, growth hormone resistance, and catabolic metabolic states. The test employs Radioimmunoassay (RIA) — a gold‑standard technique with high sensitivity and specificity — performed in an ISO 9001:2015 accredited facility. Results are integrated with clinical history, imaging, and endocrine panels to provide a comprehensive diagnostic picture.
| Feature | Our Test (UAE Premium) | Closest Alternative (Standard Panel) |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity | ~95% (ELISA‑based) |
| Method | Radioimmunoassay (RIA) – ISO 9001:2015 | Chemiluminescent Immunoassay |
| Speed | Report within 2–3 weeks (send‑out) | 5–7 working days |
Physician Insight & Safety Protocols
Mr. Prabhakar Reddy Kalathoor | Specialist Diagnostic Radiology | DHA Registration ID: 61713011: “Waiting for these results can be overwhelming, but IGFBP‑2 is a supporting marker that must be interpreted alongside clinical evaluation, imaging, and endocrine profiles. Our centre provides empathetic, clear guidance so that every patient understands the full context behind their numbers.”
Advisory Precautions for Test Preparation
Pre‑Test Requirements
Overnight fasting is mandatory for accurate IGFBP‑2 quantitation. Patients must complete the Test Send Out Consent Form (Form 35) prior to sample collection. Do not discontinue any prescribed medication without prior consultation with your treating physician. Biotin supplementation at doses ≥5 mg/day may interfere with assay results and should be withheld for 72 hours before sampling.
Exclusion Criteria & Emergency Red Flags
Contraindications and Urgent Signs
- Exclusion: Recent radioisotope therapy, ongoing biotin supplementation (≥5 mg/day), or inability to provide an overnight fasting specimen.
- Emergency Red Flags: Sudden severe abdominal pain, unexplained weight loss exceeding 5% in 2 weeks, or new‑onset neurological deficits require immediate emergency evaluation; this test should not delay that care.
Patient FAQ & Clinical Guidance
1. What is the clinical purpose of the IGFBP‑2 test?
This test quantifies insulin‑like growth factor binding protein‑2 to evaluate growth disorders, assess cancer risk (particularly colorectal and breast), and guide anti‑aging metabolic profiling. It is a supporting marker integrated with clinical and imaging findings.
2. How should I prepare for the IGFBP‑2 test?
Overnight fasting is required. Complete the mandatory Test Send Out Consent Form (Form 35) before collection. Avoid biotin supplements (≥5 mg/day) for 72 hours prior. VIP Mobile Phlebotomy is available daily from 8 AM to 11 PM for home collection.
3. When will I receive my IGFBP‑2 results?
Results are reported within 2–3 weeks after the sample is received by the laboratory. This is a send‑out test requiring referral to a specialised ISO‑accredited facility.
4. Can I eat or drink before the test?
No. You must fast for at least 8–12 hours before blood draw. Only plain water is permitted. Failure to fast may compromise result accuracy.
5. Does insurance cover the IGFBP‑2 test?
Coverage varies by insurer and policy. Direct billing verification is available via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License Number 1143 and complies with all applicable UAE federal data protection and healthcare privacy regulations:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL): Governs the lawful collection, processing, and storage of personal health data. All patient information is handled with strict confidentiality and purpose limitation.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields: Regulates the secure transmission and storage of electronic medical records and diagnostic results.
- Federal Decree-Law No. 4 of 2016 on Medical Liability: Establishes the legal framework for clinical safety, informed consent, and patient rights throughout the diagnostic process.
Your sample is processed in ISO 9001:2015 accredited laboratories with full chain‑of‑custody documentation. All results are delivered via encrypted channels to protect patient privacy.
Clinical & Logistical Metadata
| Test Name | IGF Binding Protein‑2 (IGFBP‑2), Serum |
| Price (AED) | 2,000 AED |
| Turnaround Time | 2–3 weeks |
| Sample Type / Matrix | Serum (peripheral blood) |
| Methodology Used | Radioimmunoassay (RIA) – ISO 9001:2015 |
| ICD-10-CM Code | Z13.21, E34.3 |
| LOINC Code | 35309-1 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians